Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
nerves are permanently damaged; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of nerve damage in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced nerve damage (Verbatim: nerves are permanently damaged). The outcome of the nerve damage was not reported. It was unknown if the reporter considered the nerve damage to be related to Shingles vaccine and Shingles vaccine. It was unknown if the company considered the nerve damage to be related to Shingles vaccine and Shingles vaccine. Additional Information: GSK Receipt Date: 28-MAY-2025 This case was reported by a patient via interactive digital media. The patient took both of those and no relief. He/she assuming nerves were permanently damaged and he/she would have to live with this the rest of life. The patient even had steroid injections and no relief from that either.